Professor Shirley Jansen is The Lawrence-Brown Chair of Vascular Surgery, School of Population Health, Curtin University, and Head of the Department of Vascular and Endovascular Surgery at Sir Charles Gairdner Hospital, a busy quaternary unit overseeing 1000 in-patients per year. She was awarded PhD in 1999 and The Sustained Overall Clinical Excellence Award from Sir Charles Gairdner Hospital in 2016. She has run over 40 government and industry sponsored clinical trials, the majority international as site PI, and many have led to global changes in the management of cardiovascular disease. She has supervised 10 PhDs and 3 Masters to completion and currently supervises 5 PhDs and 3 Masters. 

Shirley is the Director of the Heart and Vascular Research Institute, Harry Perkins Medical Research Institute and has led her unit to great success in over 40 first in man, pharmacological and device related trials in vascular disease. Her main research interests since PhD are in the interface between vascular physics and engineering, using biomimicry to innovate new 3 D printed devices, and development of a novel therapeutic to cure atherosclerosis. Shirley co-leads the Cardiovascualr Science & Diabetes Programme at Harry Perkins.

Shirley has wide experience in all aspects of vascular, endovascular surgery, perioperative care and prevention, and health outcomes. She has published over 160 research papers and chapters, has raised over $14million for research including MRFF and NHMRC. She has received 8 travelling fellowships in her career. She is also an inventor, and convenor of 2 national/international vascular surgical training workshops. Professor Jansen is actively engaged in cross-disciplinary collaborations locally and internationally in the areas of imaging, treatment modalities and outcomes for vascular diseases.

Professor Jansen has been awarded the status of Diamond Convenor in recognition of her long term outstanding contributions to training programs in Vascular Surgery at CTEC UWA.